QCM
JAZZ icon

Quantinno Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Quantinno Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.2M Buy
191,286
+16,928
+10% +$2.96M 0.06% 394
2025
Q4 		$29.6M Buy
174,358
+137,468
+373% +$21.1M 0.06% 381
2025
Q3 		$4.86M Buy
36,890
+1,204
+3% +$144K 0.01% 920
2025
Q2 		$3.79M Sell
35,686
-60,865
-63% -$6.61M 0.02% 910
2025
Q1 		$12M Sell
96,551
-5,017
-5% -$654K 0.08% 303
2024
Q4 		$12.5M Buy
101,568
+42,655
+72% +$5.03M 0.12% 149
2024
Q3 		$6.56M Buy
58,913
+42,924
+268% +$4.7M 0.09% 261
2024
Q2 		$1.71M Buy
15,989
+2,096
+15% +$230K 0.03% 628
2024
Q1 		$1.67M Buy
13,893
+10,473
+306% +$1.28M 0.04% 578
2023
Q4 		$421K Sell
3,420
-6,227
-65% -$777K 0.01% 866
2023
Q3 		$1.25M Buy
9,647
+3,156
+49% +$421K 0.06% 457
2023
Q2 		$805K Sell
6,491
-7,622
-54% -$1.03M 0.05% 479
2023
Q1 		$2.06M Sell
14,113
-7,538
-35% -$1.12M 0.14% 181
2022
Q4 		$3.45M Buy
21,651
+15,711
+264% +$2.3M 0.26% 67
2022
Q3 		$792K Buy
5,940
+12
+0.2% +$1.82K 0.1% 257
2022
Q2 		$925K Sell
5,928
-228
-4% -$35.1K 0.13% 197
2022
Q1 		$958K Sell
6,156
-116
-2% -$16.8K 0.15% 173
2021
Q4 		$799K Buy
+6,272
New +$824K 0.14% 173
2020
Q1 		– Sell
-2,591
Closed -$387K – 453
2019
Q4 		$387K Buy
+2,591
New +$353K 0.24% 177
2019
Q3 		– Sell
-3,258
Closed -$464K – 453
2019
Q2 		$464K Sell
3,258
-987
-23% -$133K 0.27% 144
2019
Q1 		$607K Buy
4,245
+2,041
+93% +$266K 0.39% 66
2018
Q4 		$273K Buy
+2,204
New +$327K 0.22% 233

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Quantinno Capital Management's JAZZ Position: Q1 2026 in Review

Quantinno Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 9.7% in Q1 2026, buying an estimated $2.96M and bringing the position to 191,286 shares worth $36.2M. The position accounts for 0.06% of the portfolio, ranked #394.

Quantinno Capital Management first reported a position in JAZZ in Q4 2018 and has held it in 22 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Quantinno Capital Management held 191,286 shares of Jazz Pharmaceuticals worth $36.2M as of Q1 2026.
  • Quantinno Capital Management bought 16,928 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.96M.
  • Jazz Pharmaceuticals made up 0.06% of Quantinno Capital Management's portfolio in Q1 2026, its #394 holding.
  • Quantinno Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 22 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.